The Asia Pacific market for aesthetic injectables will show strong growth during the forecast period. This growth will be primarily attributed to the rising adoption of aesthetic procedures in the untapped markets in the Asia Pacific region. Increasing aesthetic consciousness, growing urban populations with high disposable incomes, and the overall cost effectiveness of these procedures over surgical options are going to be the major drivers in these markets.
This Medtech 360 Report provides key market metrics for aesthetic injectables in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific region, across a 10-year period.
- Aesthetic Injectables - Market Insights - Asia Pacific (Supplemental)
Author(s): Raghav Tangri, MRes
Raghav Tangri is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in aesthetics device markets. Raghav has been featured in the Aesthetics Journal and has participated in several white papers on policy advocacy and analysis. Raghav also has expertise in the endoscopy device space, including the markets for gastrointestinal devices, open and laparoscopic devices, and hernia repair devices. Raghav holds a Bachelor's degree in Biotechnology from Delhi Technological University and a Master's degree in Life Sciences from Imperial College London.
Follow Raghav on Twitter:@rtangri_DRG